Global Nuclear Medicine Markets, Analysis, Forecast & Opportunities, 2016-2020 & 2021-2026
December 31, 2021 09:33 ET
|
Research and Markets
Dublin, Dec. 31, 2021 (GLOBE NEWSWIRE) -- The "Global Nuclear Medicine Market, By Type, By Diagnostic Nuclear Medicine, By Therapeutic Nuclear Medicine, By Application, By Diagnostic Applications,...
Outlook on the Radiotherapy, Radiopharmaceuticals and Nuclear Medicine Global Market to 2026 - Featuring Accuray, Bayer Pharma and Nordion Among Others
October 26, 2021 07:13 ET
|
Research and Markets
Dublin, Oct. 26, 2021 (GLOBE NEWSWIRE) -- The "Radiotherapy, Radiopharmaceuticals and Nuclear Medicine: Global Markets" report has been added to ResearchAndMarkets.com's offering. This report...
Global Nuclear Medicine/Radiopharmaceuticals Market (2021 to 2026) - Use of Radiopharmaceuticals in Neurological Applications Presents Opportunities
September 21, 2021 06:23 ET
|
Research and Markets
Dublin, Sept. 21, 2021 (GLOBE NEWSWIRE) -- The "Global Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - Technetium, PET - F-18), Therapeutic (Beta Emitters - I-131, Alpha...
Michael Didocha Joins Telix as Chief Financial Officer, Americas
August 31, 2021 07:12 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and INDIANAPOLIS, Aug. 31, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) is pleased to announce that Michael Didocha has joined the...
Mr. Ryoichi Tanaka Joins Telix Japan as Chief Operating Officer
August 05, 2021 18:14 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and KYOTO Japan, Aug. 05, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) is pleased to announce that Mr. Ryoichi Tanaka has joined the...
Ms. Helen Hovenga Joins Telix as Chief People Officer
August 03, 2021 17:48 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) is pleased to announce that Ms. Helen Hovenga has joined the Telix executive...
Kyahn Williamson Joins Telix to Lead Corporate Communications and Investor Relations
July 11, 2021 18:40 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, July 11, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) is pleased to announce that Ms. Kyahn Williamson has joined the Telix...
Global $12.17 Billion Nuclear Medicine Markets to 2028: Beta-emitters, PET, SPECT, Alpha-emitters, Brachytherapy
June 29, 2021 04:13 ET
|
Research and Markets
Dublin, June 29, 2021 (GLOBE NEWSWIRE) -- The "Nuclear Medicine Market Share, Size, Trends, Industry Analysis Report, By Type; By Modality; By Application; By End-Use; By Regions; Segment Forecast,...
Medical Cyclotron Market to Outstrip $238.21 Million by 2027 Growing Sturdy at 3.6% CAGR - COVID-19 Impact and Global Analysis by TheInsightPartners.com
June 23, 2021 11:09 ET
|
The Insight Partners
Pune, India., June 23, 2021 (GLOBE NEWSWIRE) -- Medical Cyclotron Market: Key InsightsAccording to our new research study on “Medical Cyclotron Market to 2027 – Global Analysis and Forecast – by...
Global Radiopharmaceuticals Market Report 2021: High Cost of Radiopharmaceuticals is Anticipated to Limit the Growth of the Market
May 24, 2021 05:08 ET
|
Research and Markets
Dublin, May 24, 2021 (GLOBE NEWSWIRE) -- The "Radiopharmaceuticals Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering. The...